Novatec Immundiagnostica

What Novatec Immundiagnostica does

Novatec Immundiagnostica is a German biotech firm founded in 2001, headquartered in Dernbach, operating with 11-50 employees to develop in-vitro diagnostic products including RT-PCR, NovaGen, and NovaLisa lines. Source material in this dataset primarily describes its closely associated entity Gold Standard Diagnostics Frankfurt GmbH, which functions as a healthcare diagnostic solutions provider serving clinical and veterinary laboratories worldwide. The portfolio spans four core technology platforms: chemiluminescence immunoassay (CLIA) via the Hurricane Dx random-access analyzer with 29 autoimmune assays, enzyme-linked immunosorbent assay (ELISA), real-time polymerase chain reaction (PCR), and line immunoblot, supplemented by automated instrumentation across modalities. Test menu breadth covers virology, bacteriology, parasitology, mycology, hormones, autoimmune diseases, oncology, and veterinary diagnostics (notably the VetLine EHV1 ELISA for equine herpesvirus). 2026 product activity includes expansion into advanced molecular diagnostics through PCR kits, automation, and NGS solutions, alongside specialized assays for arboviruses (Dengue, Zika, Chikungunya), mpox/orthopox (including Clade 1B), and the M371-Test for testicular cancer optimization.

The business model is a two-stream diagnostic instrument-and-reagent play: one-time hardware revenue from placement of automated platforms (Hurricane Dx analyzer) followed by recurring consumable revenue from reagent assays across all technology formats. Pricing is not publicly disclosed; customers contact sales directly for quotes, consistent with enterprise B2B laboratory sales. Distribution operates through a global partner network with regional availability for International, North America, and German-speaking markets, supplemented by a product catalog e-commerce storefront and downloadable technical brochures. Go-to-market is event-driven, anchored by participation in major industry conferences (ESCMID 2026 Munich, WHX Labs Dubai 2026, WHX Bangkok 2026) to generate demand among laboratory professionals and healthcare diagnostics decision-makers. No funding rounds, ownership details, or revenue figures are publicly disclosed in available material.

Name

Novatec Immundiagnostica

Legal name

Gold Standard Diagnostics Frankfurt GmbH

Website

https://novatec-id.com

Company type

Private

Founded year

2001

Operating status

Operating

Headcount range

11–50 employees

Short description

Novatec Immundiagnostica is a German biotech firm developing in-vitro diagnostic products (RT-PCR, NovaGen, NovaLisa) for clinical and veterinary laboratories worldwide, with associated operations spanning CLIA, ELISA, PCR, and line immunoblot technology platforms distributed through a global partner network.

Ownership category

akta.pro rank

Product category

In-Vitro Diagnostics

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Surgical and Medical Instrument Manufacturing (339112)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Laboratory Analytical Instruments (3826)

akta.pro primary industry

Immunoassay Diagnostics (ELISA, chemiluminescence, serology) (HLAAALAB)

akta.pro secondary industry

Toxicology & Therapeutic Drug Monitoring (HLAMADAG)

Keywords

• In-vitro diagnostics
• ELISA kits
• Real-time PCR kits
• Clinical diagnostics reagents
• Autoimmune disease testing

Headquarters

HQ city

Dernbach

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Diagnostic Instruments and Reagents: Sale of automated diagnostic platforms and corresponding assay reagents across multiple technology formats (CLIA, ELISA, PCR, Line Immunoblot). Instruments include the Hurricane Dx CLIA analyzer system. Reagents include assays for virology, bacteriology, parasitology, mycology, hormones, autoimmune diseases, and oncology.
2. Assay Reagents and Consumables: Recurring revenue from consumable diagnostic reagents including Serazym stool controls, arbovirus detection kits, Borrelia diagnostics, and specialty tests like the M371 testicular cancer test.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels2 records

Core offering

Novatec Immundiagnostica (operating as Gold Standard Diagnostics Frankfurt GmbH) develops, manufactures, and sells in-vitro diagnostic kits and automated instruments for clinical and veterinary laboratories. Its product range spans CLIA, ELISA, real-time PCR, and line immunoblot test kits covering autoimmune, infectious (viral, bacterial, parasitic, mycological), hormonal, and oncology indications, anchored by the Hurricane Dx CLIA analyzer and a 2026 expansion into molecular diagnostics and NGS.

Product overview

Gold Standard Diagnostics Frankfurt GmbH provides a comprehensive portfolio of diagnostic solutions organized across multiple technology platforms: CLIA (chemiluminescence), ELISA, PCR (real-time and molecular diagnostics), and Line Immunoblot. The Hurricane Dx™ represents their flagship CLIA system with 29 autoimmune assays, while their expanding molecular diagnostic line includes PCR kits for infectious diseases (Arboviruses, MPLEX MPOX/ORTHOPOX) and NGS solutions. Their automated instruments support random-access testing across all methodologies. The product ecosystem also includes specialized tests like the M371-Test for oncology and VetLine EHV1 for veterinary applications.

Differentiator

Problem solved

Functional benefit

Brands

• Hurricane Dx: Fully automated random-access chemiluminescence (CLIA) system with a comprehensive assay menu of reagents featuring 29 assays for autoimmune disease diagnostics

Products and services

• Hurricane Dx™ CLIA Analyzer System Fully automated random-access chemiluminescence (CLIA) analyzer system with 29 assays for autoimmune disease diagnostics, designed for clinical laboratory use with planned menu expansion into infectious diseases.
• Molecular Diagnostic Solutions (Real-time PCR kits, automation, and NGS) Real-time PCR kits, automation, and next-generation sequencing (NGS) solutions for molecular diagnostics, expanding the company's offering into advanced molecular workflows.
• MPLEX MPOX, ORTHOPOX, CLADE 1B Real-Time PCR Assay Real-Time PCR assay (1 x 96 reactions) for the detection of MPOX, Orthopox, and Clade 1B variants, for clinical and public health laboratory use.
• Serazym® Stool ELISA ELISA-based diagnostic test kit for the detection of gastrointestinal infections, for clinical laboratory use.
• Serazym® Stuhltest-Kontrollen (Stool Test Controls) Quality control materials (stool test controls) used as part of the Serazym product line to support quality assurance in gastrointestinal diagnostics.
• Arboviruses Diagnostic Portfolio (Dengue, Zika, Chikungunya) Diagnostic test portfolio for the detection of arboviruses including Dengue, Zika, and Chikungunya, supporting infectious disease surveillance and clinical diagnostics.
• Borrelia Diagnostics (Lyme Disease) Diagnostic testing solutions for the detection of Borrelia bacteria causing Lyme disease, including line immunoblot and ELISA workflows.
• VetLine EHV1 ELISA ELISA test for qualitative or semi-quantitative antibody detection of Equine Herpesvirus type 1 (EHV-1) in equine serum, supporting veterinary diagnostic laboratories and notifiable disease reporting (e.g., under the German Animal Disease Notification Ordinance from 10 March 2026).
• M371-Test (Testicular Cancer Diagnostics) Diagnostic test designed to optimize the clinical workflow and accuracy of testicular cancer diagnostics.
• Automated Diagnostic Platforms and Instruments Automated laboratory instruments and platforms for diagnostic testing across multiple methodologies (CLIA, ELISA, PCR, line immunoblot), including the Hurricane Dx random-access analyzer.

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature8 records

Scale indicators2 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• AESKU.GROUP: German IVD group with comparable autoimmune, infectious-disease, and veterinary diagnostics product lines. A particularly relevant regional peer given Gold Standard Diagnostics' Germany-based operations.
• DRG Instruments (DRG International): Germany-based IVD manufacturer with ELISA, CLIA, and clinical chemistry reagent lines. Closely comparable mid-sized European competitor targeting autoimmune and infectious-disease labs.
• Meridian Bioscience: U.S.-headquartered IVD manufacturer with strong immunoassay and molecular test menus targeting clinical labs. Comparable in scale and product breadth to Gold Standard Diagnostics' multi-platform offering.
• DiaSorin: Italian-headquartered IVD specialist focused on chemiluminescence immunoassays (CLIA) and molecular diagnostics. Closely comparable to Gold Standard Diagnostics' Hurricane Dx CLIA franchise and expanding molecular diagnostics line.
• EUROIMMUN (Revvity): German IVD company historically focused on autoimmune diagnostics via ELISA, indirect immunofluorescence, and chemiluminescence; now part of Revvity. Closest functional analog to Gold Standard Diagnostics' autoimmune CLIA franchise.

Broad incumbents

• QIAGEN: Global molecular-diagnostics leader with broad PCR and NGS reagent portfolios. Most relevant as Gold Standard Diagnostics expands into real-time PCR and NGS in 2026.
• Hologic: Diversified diagnostics and women's-health company with molecular assays and Panther automation. Relevant as Gold Standard Diagnostics moves deeper into molecular infectious-disease testing.
• Bio-Rad Laboratories: Large diversified IVD and life-science company with deep ELISA, immunoassay, and clinical-diagnostics offerings. Overlaps directly with Gold Standard Diagnostics' ELISA and autoimmune menu and competes for clinical-lab budgets.
• QuidelOrtho: U.S. diagnostics company formed from the Quidel-Ortho merger, spanning immunoassays, rapid diagnostics, and clinical chemistry. Competes with Gold Standard Diagnostics in autoimmune and infectious-disease testing.

Emerging players

• Tecan: Switzerland-based supplier of laboratory automation and immunoassay instruments. Comparable through the Hurricane Dx automated instrument platform and broader automated-platform roadmap.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/novatec-immundiagnostica-gmbh

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Novatec Immundiagnostica